DAFNA Capital Management LLC - Q4 2021 holdings

$398 Million is the total value of DAFNA Capital Management LLC's 87 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 23.8% .

 Value Shares↓ Weighting
STXS  STEREOTAXIS INC$84,819,000
+15.2%
13,680,5540.0%21.33%
+9.2%
BPMC  BLUEPRINT MEDICINES CORP$22,162,000
+4.2%
206,9110.0%5.57%
-1.3%
FATE BuyFATE THERAPEUTICS INC$21,775,000
+6.7%
372,160
+8.1%
5.48%
+1.1%
ACET BuyADICET BIO INC$12,823,000
+334.7%
733,172
+94.8%
3.22%
+311.7%
XENE SellXENON PHARMACEUTICALS INC$12,579,000
+102.5%
402,667
-1.0%
3.16%
+91.9%
ARNA  ARENA PHARMACEUTICALS INC$11,117,000
+56.1%
119,6150.0%2.80%
+47.9%
IDYA  IDEAYA BIOSCIENCES INC$10,876,000
-7.3%
460,0610.0%2.74%
-12.1%
DXCM SellDEXCOM INC$9,739,000
-15.8%
18,138
-14.2%
2.45%
-20.1%
KRTX SellKARUNA THERAPEUTICS INC$9,487,000
+4.0%
72,423
-2.9%
2.39%
-1.4%
NRIX  NURIX THERAPEUTICS INC$8,868,000
-3.4%
306,3200.0%2.23%
-8.4%
MORF  MORPHIC HLDG INC$8,598,000
-16.3%
181,4670.0%2.16%
-20.7%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$8,007,000
-34.6%
58,100
-34.1%
2.01%
-38.0%
SAGE  SAGE THERAPEUTICS INC$7,670,000
-4.0%
180,3060.0%1.93%
-9.0%
MRUS BuyMERUS N V$7,190,000
+147.7%
226,089
+71.3%
1.81%
+134.8%
NBIX SellNEUROCRINE BIOSCIENCES INC$7,125,000
-12.2%
83,655
-1.2%
1.79%
-16.8%
SNDX BuySYNDAX PHARMACEUTICALS INC$6,491,000
+320.9%
296,535
+267.4%
1.63%
+299.0%
IBB  ISHARES TR NASDAQ BIOTECHetf$6,242,000
-5.6%
40,9000.0%1.57%
-10.5%
CYTK SellCYTOKINETICS INC$6,112,000
-2.3%
134,094
-23.4%
1.54%
-7.4%
CBAY BuyCYMABAY THERAPEUTICS INC$6,042,000
+215.7%
1,787,569
+241.0%
1.52%
+199.0%
CSII BuyCARDIOVASCULAR SYS INC$5,390,000
-15.3%
286,988
+48.1%
1.36%
-19.7%
RVMD BuyREVOLUTION MEDICINES INC$5,342,000
-7.4%
212,231
+1.2%
1.34%
-12.3%
ATRC  ATRICURE INC$5,008,000
-0.0%
72,0290.0%1.26%
-5.3%
RCUS SellARCUS BIOSCIENCES INC$4,743,000
+10.0%
117,200
-5.3%
1.19%
+4.3%
MEIP BuyMEI PHARMA INC$4,712,000
+166.4%
1,764,846
+175.3%
1.18%
+152.7%
ISEE BuyIVERIC BIO INC$4,614,000
+31.3%
275,976
+27.6%
1.16%
+24.5%
OTIC SellOTONOMY INC$4,577,000
+0.2%
2,200,297
-7.5%
1.15%
-5.0%
NTUS BuyNATUS MED INC$4,524,000
+88.6%
190,635
+99.3%
1.14%
+78.9%
ARAY  ACCURAY INC$4,492,000
+20.8%
941,8000.0%1.13%
+14.5%
 RADIUS HEALTH INCnote 3.000% 9/0$3,860,000
+6.3%
4,000,0000.0%0.97%
+0.8%
NewPARDES BIOSCIENCES INC$3,822,000233,500
+100.0%
0.96%
FSTX  F-STAR THERAPEUTICS INC$3,483,000
-31.4%
693,7850.0%0.88%
-35.0%
ALEC BuyALECTOR INC$3,206,000
+30.8%
155,247
+44.5%
0.81%
+24.0%
AFMD SellAFFIMED N V$3,153,000
-47.1%
571,282
-40.8%
0.79%
-49.9%
AXGN NewAXOGEN INC$3,112,000332,103
+100.0%
0.78%
KALV BuyKALVISTA PHARMACEUTICALS INC$2,522,000
-23.6%
190,663
+0.8%
0.63%
-27.6%
ITOS SellITEOS THERAPEUTICS INC$2,518,000
+12.3%
54,090
-34.9%
0.63%
+6.4%
GLPG SellGALAPAGOS NVspon adr$2,353,000
-42.4%
42,675
-45.1%
0.59%
-45.4%
BMEA NewBIOMEA FUSION INC$2,339,000313,923
+100.0%
0.59%
RIGL BuyRIGEL PHARMACEUTICALS INC$2,329,000
-20.7%
879,000
+8.7%
0.59%
-24.8%
TPTX BuyTURNING POINT THERAPEUTICS I$2,216,000
-20.5%
46,452
+10.7%
0.56%
-24.6%
ATHA  ATHIRA PHARMA INC$2,098,000
+38.9%
160,9830.0%0.53%
+31.7%
VKTX  VIKING THERAPEUTICS INC$2,058,000
-26.8%
447,4000.0%0.52%
-30.6%
AERI  AERIE PHARMACEUTICALS INC$2,029,000
-38.4%
289,0400.0%0.51%
-41.6%
COGT  COGENT BIOSCIENCES INC$1,918,000
+2.0%
223,5540.0%0.48%
-3.4%
ETNB Buy89BIO INC$1,891,000
-23.8%
144,653
+14.2%
0.48%
-27.7%
KNTE  KINNATE BIOPHARMA INC$1,886,000
-23.1%
106,4530.0%0.47%
-27.1%
MREO  MEREO BIOPHARMA GROUP PLCads$1,803,000
-33.9%
1,126,6130.0%0.45%
-37.3%
RGLS NewREGULUS THERAPEUTICS INC$1,750,0005,555,555
+100.0%
0.44%
VERO SellVENUS CONCEPT INC$1,659,000
-40.6%
975,687
-12.4%
0.42%
-43.7%
IPSC BuyCENTURY THERAPEUTICS INC$1,588,000
-21.1%
100,135
+25.2%
0.40%
-25.3%
KURA BuyKURA ONCOLOGY INC$1,552,000
-17.8%
110,829
+9.9%
0.39%
-22.2%
BWAY  BRAINSWAY LTDsponsored ads$1,540,000
-4.5%
200,0000.0%0.39%
-9.6%
SURF NewSURFACE ONCOLOGY INC$1,506,000315,000
+100.0%
0.38%
ASND NewASCENDIS PHARMA A/Ssponsored adr$1,480,00011,000
+100.0%
0.37%
MGNX  MACROGENICS INC$1,445,000
-23.3%
90,0000.0%0.36%
-27.4%
NGM BuyNGM BIOPHARMACEUTICALS INC$1,425,000
+3.6%
80,485
+22.9%
0.36%
-1.9%
STIM  NEURONETICS INC$1,399,000
-32.0%
313,7170.0%0.35%
-35.5%
RDUS BuyRADIUS HEALTH INC$1,328,000
+637.8%
191,978
+1224.0%
0.33%
+595.8%
 AERIE PHARMACEUTICALS INCnote 1.500%10/0$1,243,000
-9.6%
1,500,0000.0%0.31%
-14.2%
NewTHESEUS PHARMACEUTICALS INC$1,236,00097,500
+100.0%
0.31%
WVE NewWAVE LIFE SCIENCES LTD$1,225,000390,161
+100.0%
0.31%
NXTC BuyNEXTCURE INC$1,126,000
-9.0%
187,696
+2.3%
0.28%
-13.7%
BDTX NewBLACK DIAMOND THERAPEUTICS I$1,099,000206,100
+100.0%
0.28%
PHAS SellPHASEBIO PHARMACEUTICALS INC$988,000
-47.3%
378,611
-37.2%
0.25%
-50.1%
MASI  MASIMO CORP$878,000
+8.1%
3,0000.0%0.22%
+2.8%
MRSN  MERSANA THERAPEUTICS INC$872,000
-34.1%
140,2630.0%0.22%
-37.6%
CGEN  COMPUGEN LTDord$866,000
-28.0%
201,5020.0%0.22%
-31.7%
 FIELD TRIP HEALTH LTD$839,000
-46.4%
340,9000.0%0.21%
-49.2%
ASLN  ASLAN PHARMACEUTICALS LTDads$820,000
-37.1%
732,5000.0%0.21%
-40.5%
HARP  HARPOON THERAPEUTICS INC$794,000
-4.5%
105,1630.0%0.20%
-9.1%
LVTX  LAVA THERAPEUTICS NV$766,000
-7.2%
139,3320.0%0.19%
-11.9%
LRMR BuyLARIMAR THERAPEUTICS INC$757,000
+1.7%
70,177
+8.8%
0.19%
-3.6%
HOOK SellHOOKIPA PHARMA INC$747,000
-60.6%
320,444
-0.5%
0.19%
-62.6%
SCYX NewSCYNEXIS INC$740,000121,242
+100.0%
0.19%
PRQR SellPROQR THERAPEUTICS N V$685,000
-72.4%
85,476
-71.2%
0.17%
-73.9%
STRO SellSUTRO BIOPHARMA INC$670,000
-58.3%
45,000
-47.1%
0.17%
-60.6%
CMPX NewCOMPASS THERAPEUTICS INC$622,000196,091
+100.0%
0.16%
INFI  INFINITY PHARMACEUTICALS INC$531,000
-34.3%
236,1600.0%0.13%
-37.4%
PHVS BuyPHARVARIS N V$528,000
-15.1%
36,720
+4.7%
0.13%
-19.4%
ADAP NewADAPTIMMUNE THERAPEUTICS PLCsponds adr$511,000136,266
+100.0%
0.13%
INGN  INOGEN INC$510,000
-21.1%
15,0000.0%0.13%
-25.1%
BOLT  BOLT BIOTHERAPEUTICS INC$490,000
-61.3%
100,0000.0%0.12%
-63.4%
MDGL  MADRIGAL PHARMACEUTICALS INC$475,000
+6.3%
5,6000.0%0.12%0.0%
SRGA  SURGALIGN HOLDINGS INC$415,000
-34.3%
579,7100.0%0.10%
-38.1%
ANNX BuyANNEXON INC$354,000
-18.4%
30,796
+32.2%
0.09%
-22.6%
GNFT SellGENFIT S Aads$302,000
-56.7%
60,448
-67.9%
0.08%
-58.9%
LCTX NewLINEAGE CELL THERAPEUTICS IN$196,00080,000
+100.0%
0.05%
VBLT ExitVASCULAR BIOGENICS LTD$0-55,000
-100.0%
-0.03%
ALPN ExitALPINE IMMUNE SCIENCES INC$0-111,501
-100.0%
-0.32%
IFRX ExitINFLARX NV$0-600,000
-100.0%
-0.41%
KDMN ExitKADMON HLDGS INC$0-314,561
-100.0%
-0.73%
FSII ExitFS DEVELOPMENT CORP II$0-299,950
-100.0%
-0.79%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-587,456
-100.0%
-3.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STEREOTAXIS INC42Q3 202327.6%
ATRICURE INC42Q3 202311.4%
MASIMO CORPORATION42Q3 20231.8%
ASCENDIS PHARMA A S SPONSORED34Q3 20234.5%
AERIE PHARMACEUTICALS INC33Q3 20224.2%
GALAPAGOS NV-SPON ADR33Q3 20233.8%
XENON PHARMACEUTICALS INC33Q3 20233.6%
NEUROCRINE BIOSCIENCES INC32Q3 20232.9%
JOHNSON AND JOHNSON32Q1 20211.2%
ISHARES TR NASDQ BIOTECH30Q3 20234.0%

View DAFNA Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
DAFNA Capital Management LLC Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stereotaxis, Inc.March 08, 201813,680,55423.4%
SUNESIS PHARMACEUTICALS INCFebruary 14, 2018983,0002.9%
SUNESIS PHARMACEUTICALS INCFebruary 14, 20171,133,5835.4%
WINDTREE THERAPEUTICS INC /DE/February 14, 2017208,3332.4%
ANAVEX LIFE SCIENCES CORP.Sold outFebruary 16, 201600.0%
DISCOVERY LABORATORIES INC /DE/February 16, 201610,658,6999.2%
PRECISION OPTICS CORPORATION, INC.February 13, 2015311,5375.0%
TearLab CorpFebruary 14, 2013939,2393.2%
VIKING SYSTEMS INCFebruary 14, 20123,781,4685.2%

View DAFNA Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15

View DAFNA Capital Management LLC's complete filings history.

Compare quarters

Export DAFNA Capital Management LLC's holdings